Search

Your search keyword '"pancreatic ductal adenocarcinomas"' showing total 32 results

Search Constraints

Start Over You searched for: Descriptor "pancreatic ductal adenocarcinomas" Remove constraint Descriptor: "pancreatic ductal adenocarcinomas" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
32 results on '"pancreatic ductal adenocarcinomas"'

Search Results

1. Cancer cell membrane-coated upconversion nanoparticles/ZnxMn1-xS core-shell nanoparticles for targeted photodynamic and chemodynamic therapy of pancreatic cancer

2. A nomogram diagnostic prediction model of pancreatic metastases of small cell lung carcinoma based on clinical characteristics, radiological features and biomarkers.

Catalog

Books, media, physical & digital resources

3. TRIM11 suppresses ferritinophagy and gemcitabine sensitivity through UBE2N/TAX1BP1 signaling in pancreatic ductal adenocarcinoma.

4. Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11p110.

5. Mitochondrial DNA-boosted dendritic cell-based nanovaccination triggers antitumor immunity in lung and pancreatic cancers.

6. Radiomics-Assisted Presurgical Prediction for Surgical Portal Vein-Superior Mesenteric Vein Invasion in Pancreatic Ductal Adenocarcinoma

7. Radiomics-Assisted Presurgical Prediction for Surgical Portal Vein-Superior Mesenteric Vein Invasion in Pancreatic Ductal Adenocarcinoma.

8. Prognostic significance of p16 protein in pancreatic ductal adenocarcinoma.

9. The Eighth Edition of the American Joint Committee on Cancer Distant Metastases Stage Classification for Metastatic Pancreatic Neuroendocrine Tumors Might Be Feasible for Metastatic Pancreatic Ductal Adenocarcinomas.

10. Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology

11. HBXIP protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.

12. Avarol Induces Apoptosis in Pancreatic Ductal Adenocarcinoma Cells by Activating PERK–eIF2α–CHOP Signaling

13. Biomimetic nanoparticles delivered hedgehog pathway inhibitor to modify tumour microenvironment and improved chemotherapy for pancreatic carcinoma.

14. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole‐tumor CT texture analysis as quantitative biomarkers.

15. Differentiation of mass-forming focal pancreatitis from pancreatic ductal adenocarcinoma: value of characterizing dynamic enhancement patterns on contrast-enhanced MR images by adding signal intensity color mapping.

16. Immunosuppressive microenvironment improvement and treatment of aggressive malignancy pancreatic ductal adenocarcinoma based on local administration of injectable hydrogel.

17. Cancer cell membrane-coated upconversion nanoparticles/Zn x Mn 1-x S core-shell nanoparticles for targeted photodynamic and chemodynamic therapy of pancreatic cancer.

18. Synergistic combination of valproic acid and oncolytic parvovirus H‐1PV as a potential therapy against cervical and pancreatic carcinomas

19. CLIC1 overexpression is associated with poor prognosis in pancreatic ductal adenocarcinomas.

20. [Retracted] MicroRNA‑148a suppresses epithelial‑mesenchymal transition and invasion of pancreatic cancer cells by targeting Wnt10b and inhibiting the Wnt/β‑catenin signaling pathway.

21. A nomogram diagnostic prediction model of pancreatic metastases of small cell lung carcinoma based on clinical characteristics, radiological features and biomarkers.

22. Synergistic combination of valproic acid and oncolytic parvovirus H-1 PV as a potential therapy against cervical and pancreatic carcinomas.

23. Potential epigenetic biomarkers for the diagnosis and prognosis of pancreatic ductal adenocarcinomas.

24. Protective or Risk Factors for Postoperative Pancreatic Fistulas in Malignant Pathology.

25. Molecular alterations in pancreatic tumors.

26. Galactosyltransferase B4GALT1 confers chemoresistance in pancreatic ductal adenocarcinomas by upregulating N-linked glycosylation of CDK11 p110 .

28. Long non-coding RNA MVIH promotes cell proliferation, migration, invasion through regulating multiple cancer-related pathways, and correlates with worse prognosis in pancreatic ductal adenocarcinomas.

29. Tumor Microenvironment Modulation by Cyclopamine Improved Photothermal Therapy of Biomimetic Gold Nanorods for Pancreatic Ductal Adenocarcinomas.

30. Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer.

31. Complement in Pancreatic Disease-Perpetrator or Savior?

32. Perineural Invasion and TAMs in Pancreatic Ductal Adenocarcinomas: Review of the Original Pathology Reports Using Immunohistochemical Enhancement and Relationships with Clinicopathological Features.